Furthermore, galanin receptor type 2 (GALR2) and G-protein-coupled receptor (GPCR) induce the aggressive growth of SCCHN and stimulate angiogenesis through p38 MAPK-mediated phosphorylation of TTP. This evidence concerns the gene GALR2 and head and neck squamous cell carcinoma.